http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101301037-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-98 |
| filingDate | 2007-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101301037-B1 |
| titleOfInvention | Anti-aging agent |
| abstract | The present invention provides a novel use of the components extracted from the ovarian membrane of salmon. It is an anti-aging agent containing a component extracted by treating salmon ovarian membranes with protease. The anti-aging agent can be used as one of IGF-1 elevated, skin roughening and acceleration pulse wave aging index synergist. The anti-aging agent can raise the IGF-1 value which decreases with aging again, and can alleviate and improve the symptoms associated with aging. Anti-aging agents can improve skin roughness with aging. The anti-aging agent can raise the acceleration pulse wave aging index lowered by aging and alleviate and improve the symptoms caused by the decrease of peripheral blood circulation. |
| priorityDate | 2006-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.